Recent years have been associated with the development of various sensor-based
technologies in response to the undeniable need for the rapid and precise analysis of an …

Introduction Up to now, numerous randomized controlled trials (RCTs) have examined
various drugs as possible treatments for Coronavirus Disease 2019 (COVID-19), but the …

Background: Vitamin D is a likely candidate for treatment as its immune modulating
characteristics have effects on coronavirus disease 2019 (COVID-19) patients. It was sought …

Objectives Our study aims at comparing the efficacy and safety of IFN-based therapy
(lopinavir/ritonavir, ribavirin, and interferon β-1b) vs. favipiravir (FPV) in a cohort of …

Background Remdesivir, an antiviral agent able to reduce inflammatory cascade
accompanying severe, life-threatening pneumonia, became the first drug approved by the …

Coronavirus disease (COVID-19) is the current global public health concern. To date, no
specific, effective, and approved treatment is available. With the rapid increase in the rate of …

Since the first detection of a cluster of COVID-19 patients in China in late 2019, it becomes a
global concern due to its transmissibility and ability to progress patients in severe respiratory …

Purpose To evaluate the safety and efficacy of favipiravir, which is prescribed for the
treatment of patients with mild-to-moderate coronavirus disease 2019 (COVID-19) in India …

Objectives The full range of long‐term health consequences in intensive care unit (ICU)
survivors with COVID‐19 is unclear. This study aims to investigate the role of ventilatory …

Since the beginning of the SARS-CoV-2 pandemic, the treatments and management of the
deadly COVID-19 disease have made great progress. The strategies for developing novel …